Modified technique for the creation of an orthotopic neobladder in patients with shortened mesentery: making up the difference between the bladder and the urethral stump.
Bioanalytical LC-QTOF/MS Method for a N -phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies.
Autorzy:
Ramos ACM; Laboratory of Biopharmacy and Pharmacokinetics (BioPK), Faculty of Pharmacy, Federal University of Goiás, Goiânia 74605-170, GO, Brazil. Rezende KR; Laboratory of Biopharmacy and Pharmacokinetics (BioPK), Faculty of Pharmacy, Federal University of Goiás, Goiânia 74605-170, GO, Brazil. Teixeira CM; Laboratory of Biopharmacy and Pharmacokinetics (BioPK), Faculty of Pharmacy, Federal University of Goiás, Goiânia 74605-170, GO, Brazil. Fernandes AR; Laboratory of Chromatography and Mass Spectrometry (LaCEM), Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, GO, Brazil. Santos H; Laboratory of Chromatography and Mass Spectrometry (LaCEM), Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, GO, Brazil. MachadoRD; Laboratory of Biopharmacy and Pharmacokinetics (BioPK), Faculty of Pharmacy, Federal University of Goiás, Goiânia 74605-170, GO, Brazil. Menegatti R; Laboratory of Pharmaceutical Medicinal Chemistry (LQFM), Faculty of Pharmacy, Federal University of Goiás, Goiânia 74605-170, GO, Brazil. Vaz BG; Laboratory of Chromatography and Mass Spectrometry (LaCEM), Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, GO, Brazil. Chaves AR; Laboratory of Chromatography and Mass Spectrometry (LaCEM), Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, GO, Brazil.
Improvement in Solubility-Permeability Interplay of Psoralens from Brosimum gaudichaudii Plant Extract upon Complexation with Hydroxypropyl-β-cyclodextrin.
Autorzy:
MachadoRD; Laboratório de Biofarmácia e Farmacocinética (BioPk), Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Silva JCG; Laboratório de Biofarmácia e Farmacocinética (BioPk), Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Silva LAD; Laboratório de Nanotecnologia Farmacêutica e Sistemas de Liberação de Fármacos (FarmaTec), Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Oliveira GAR; Laboratório de Ressonância Magnética Nuclear (LabRMN), Instituto de Química, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Lião LM; Laboratório de Ressonância Magnética Nuclear (LabRMN), Instituto de Química, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Lima EM; Laboratório de Nanotecnologia Farmacêutica e Sistemas de Liberação de Fármacos (FarmaTec), Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. de Morais MC; Laboratório de PD&I de Bioprodutos, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. da Conceição EC; Laboratório de PD&I de Bioprodutos, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil. Rezende KR; Laboratório de Biofarmácia e Farmacocinética (BioPk), Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia 74605-170, GO, Brazil.
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
Autorzy:
Long L; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Ormiston ML; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Yang X; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Southwood M; Department of Pathology, Papworth Hospital, Papworth Everard, Cambridge, UK. Gräf S; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. MachadoRD; University of Lincoln, School of Life Sciences, Lincoln, UK. Mueller M; Novartis Institutes for Biomedical Research, Basel, Switzerland. Kinzel B; Novartis Institutes for Biomedical Research, Basel, Switzerland. Yung LM; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Wilkinson JM; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Moore SD; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Drake KM; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Aldred MA; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. Yu PB; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Upton PD; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Morrell NW; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Pokaż więcej
Źródło:
Nature medicine [Nat Med] 2015 Jul; Vol. 21 (7), pp. 777-85. Date of Electronic Publication: 2015 Jun 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies